Harmony Biosciences Holdings, Inc. - 10-Q Filing

Harmony Biosciences reports Q3 2025 financial results including significant customer concentration and debt obligations.

SEC EDGAR ·

Tickers: $HRMY

Read the full article at SEC EDGAR

More Regulatory news